Cell type related differences in staining with pentameric thiophene derivatives

Cytometry Part A

Volumn 85, Issue 7, 2014, Pages 628-635

  Cieślar Pobuda, Artur ^a,b   Bäck, Marcus ^a   Magnusson, Karin ^a   Jain, Mayur V ^a   Rafat, Mehrdad ^a   Ghavami, Saeid ^c,d   Nilsson, K Peter R ^a   Los, Marek J ^a,e  

^a LINKÖPING UNIVERSITY   (Sweden)

^b SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

^c Manitoba Institute of Child Health   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Cancer stem cells; Fluorescent probes; Luminescent conjugated oligothiophenes

Indexed keywords

FLUORESCENT DYE; PROTEIN P53; THIOPHENE DERIVATIVE;

CANCER STEM CELL; CELLS; CHEMISTRY; CLASSIFICATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HCT116 CELL LINE; HEK293 CELL LINE; HELA CELL LINE; HUMAN; LUMINESCENCE; MCF 7 CELL LINE; METABOLISM; PROCEDURES; STAINING; TUMOR CELL LINE;

CELL LINE, TUMOR; CELLS; FLOW CYTOMETRY; FLUORESCENT DYES; HCT116 CELLS; HEK293 CELLS; HELA CELLS; HUMANS; LUMINESCENT MEASUREMENTS; MCF-7 CELLS; MICROSCOPY, FLUORESCENCE; NEOPLASTIC STEM CELLS; STAINING AND LABELING; THIOPHENES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84902955958     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.22437     Document Type: Article

References (31)

1. Barbarella G, Melucci M, Sotgiu G. The versatile thiophene: An overview of recent research on thiophene-based materials. Adv Mater 2005;17:1581-1593.
2. Palama I, Di Maria F, Viola I, Fabiano E, Gigli G, Bettini C, Barbarella G. Live-cell-permeant thiophene fluorophores and cell-mediated formation of fluorescent fibrils. J Am Chem Soc 2011;133:17777-17785.
3. Capobianco ML, Naldi M, Zambianchi M, Barbarella G. Oligothiophene phosphoramidites for oligonucleotide labelling. Tetrahedron Lett 2005;46:8181-8184.
4. Capobianco ML, Barbarella G, Manetto A. Oligothiophenes as fluorescent markers for biological applications. Molecules 2012;17:910-933.
5. Aslund A, Sigurdson CJ, Klingstedt T, Grathwohl S, Bolmont T, Dickstein DL, Glimsdal E, Prokop S, Lindgren M, Konradsson P, et al. Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem Biol 2009;4:673-684.
6. Sigurdson CJ, Nilsson KP, Hornemann S, Heikenwalder M, Manco G, Schwarz P, Ott D, Rulicke T, Liberski PP, Julius C, et al. De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Natl Acad Sci USA 2009;106:304-309.
7. Nilsson KP, Joshi-Barr S, Winson O, Sigurdson CJ. Prion strain interactions are highly selective. J Neurosci 2010;30:12094-12102.
8. Hammarstrom P, Simon R, Nystrom S, Konradsson P, Aslund A, Nilsson KPR. A fluorescent pentameric thiophene derivative detects in vitro-formed prefibrillar protein aggregates. Biochemistry 2010;49:6838-6845.
9. Bjork P, Peter RNK, Lenner L, Kagedal B, Persson B, Inganas O, Jonasson J. Conjugated polythiophene probes target lysosome-related acidic vacuoles in cultured primary cells. Mol Cell Probes 2007;21:329-337.
10. Mahajan V, Klingstedt T, Simon R, Nilsson KP, Thueringer A, Kashofer K, Haybaeck J, Denk H, Abuja PM, Zatloukal K. Cross beta-sheet conformation of keratin 8 is a specific feature of Mallory-Denk bodies compared with other hepatocyte inclusions. Gastroenterology 2011;141:1080-1090 e1-7.
11. Nilsson KP, Rydberg J, Baltzer L, Inganas O. Self-assembly of synthetic peptides control conformation and optical properties of a zwitterionic polythiophene derivative. Proc Natl Acad Sci USA 2003;100:10170-10174.
12. Klingstedt T, Aslund A, Simon RA, Johansson LB, Mason JJ, Nystrom S, Hammarstrom P, Nilsson KP. Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates. Org Biomol Chem 2011;9:8356-8370.
13. Klingstedt T, Blechschmidt C, Nogalska A, Prokop S, Haggqvist B, Danielsson O, Engel WK, Askanas V, Heppner FL, Nilsson KP. Luminescent conjugated oligothiophenes for sensitive fluorescent assignment of protein inclusion bodies. Chembiochem 2013;14:607-616.
14. Sigurdson CJ, Nilsson KP, Hornemann S, Manco G, Polymenidou M, Schwarz P, Leclerc M, Hammarstrom P, Wuthrich K, Aguzzi A. Prion strain discrimination using luminescent conjugated polymers. Nat Methods 2007;4:1023-1030.
15. Margalith I, Suter C, Ballmer B, Schwarz P, Tiberi C, Sonati T, Falsig J, Nystrom S, Hammarstrom P, Aslund A, et al. Polythiophenes inhibit prion propagation by stabilizing prion protein (PrP) aggregates. J Biol Chem 2012;287:18872-18887.
16. Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, Brown PO. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 2002;99:12877-12882.
17. Goodpaster T, Legesse-Miller A, Hameed MR, Aisner SC, Randolph-Habecker J, Coller HA. An immunohistochemical method for identifying fibroblasts in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem 2008;56:347-358.
18. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
19. Farahani E, Patra HK, Jangamreddy JR, Rashedi I, Kawalec M, Rao RK, Batakis P, Wiechec E. Cell adhesion molecules and their relation to (cancer) cell stemness. Carcinogenesis 2014;35.
20. Hombach-Klonisch S, Panigrahi S, Rashedi I, Seifert A, Alberti E, Pocar P, Kurpisz M, Schulze-Osthoff K, Mackiewicz A, Los M. Adult stem cells and their trans-differentiation potential-Perspectives and therapeutic applications. J Mol Med (Berl) 2008;86:1301-1304.
21. Hombach-Klonisch S, Paranjothy T, Wiechec E, Pocar P, Mustafa T, Seifert A, Zahl C, Gerlach KL, Biermann K, Steger K, et al. Cancer stem cells as targets for cancer therapy: Selected cancers as examples. Arch Immunol Ther Exp (Warsz) 2008;56:165-180.
22. Wasik AM, Grabarek J, Pantovic A, Cieślar-Pobuda A, Asgari HR, Bundgaard-Nielsen C, Rafat M, Dixon IMC, Ghavami S, Los MJ. Reprogramming and carcinogenesis-Parallels and distinctions. Int Rev Cell Mol Biol 2014;308.
23. Bom APDA, Rangel LP, Costa DCF, de Oliveira GAP, Sanches D, Braga CA, Gava LM, Ramos CHI, Cepeda AOT, Stumbo AC, et al. Mutant p53 aggregates into prion-like amyloid oligomers and fibrils implications for cancER. J Biol Chem 2012;287:28152-28162.
24. Levy CB, Stumbo AC, Bom APDA, Portari EA, Cordeiro Y, Silva JL, DeMoura-Gallo CV. Co-localization of mutant p53 and amyloid-like protein aggregates in breast tumors (vol 43, pg 60, 2011). Int J Biochem Cell Biol 2011;43:946-946.
25. Jerry DJ, Tao LW, Yan HH. Regulation of cancer stem cells by p53. Breast Cancer Res 2008;10.
26. Spike BT, Wahl GM. p53, Stem Cells, and Reprogramming: Tumor suppression beyond guarding the genome. Genes Cancer 2011;2:404-419.
27. Godar S, Ince TA, Bell GW, Feldser D, Donaher JL, Bergh J, Liu A, Miu K, Watnick RS, Reinhardt F and others. Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression. Cell 2008;134:62-73.
28. Zhang M, Behbod F, Atkinson RL, Landis MD, Kittrell F, Edwards D, Medina D, Tsimelzon A, Hilsenbeck S, Green JE, et al. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res 2008;68:4674-4682.
29. Meletis K, Wirta V, Hede SM, Nister M, Lundeberg J, Frisen J. P53 suppresses the self-renewal of adult neural stem cells. Development 2006;133:363-369.
30. Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M, Bus CJ, Kadkhoda K, Wiechec E, Halayko AJ, et al. Apoptosis and cancer: Mutations within caspase genes. J Med Genet 2009;46:497-510.
31. Wiechec E. Implications of genomic instability in the diagnosis and treatment of breast cancer. Expert Rev Mol Diagn 2011;11:445-453.